Ischemia in Patients With Non-obstructive Disease (INOCA) in Italy INOCA IT Multicenter Registry"

Last updated: April 8, 2024
Sponsor: IRCCS San Raffaele
Overall Status: Completed

Phase

N/A

Condition

Vascular Diseases

Thrombosis

Chest Pain

Treatment

not required

Clinical Study ID

NCT05164640
RF-2019-12369486
  • Ages 18-75
  • All Genders

Study Summary

Prospective, interventional, multicentre, non-randomized, single-arm open-label study that aims to enroll 200 consecutive patients with suspected chronic ischemic heart disease in the absence of obstructive coronary artery disease (INOCA) at clinically indicated coronary angiography in 3 Italian centers.

During coronary angiography, these patients will be simultaneously subjected to a functional and coronary physiology study (according to the methods reported below):

  • Functional evaluation with fractional flow reserve (FFR), instantaneous wave-free ratio (iFR), Resting Full-Cycle Ratio (RFR) of angiographic stenosis> 50%;

  • In the presence of coronary angiographic stenosis <50% or> 50% but in the presence of a negative functional assessment (FFR> 0.80 and iFR / RFR> 0.90), coronary flow reserve (CFR) and index of microvascular resistance (IMR) will be measured. IMR and CFR will be assessed using intra-coronary guidance;

  • In the presence of CFR> 2.0 and IMR <25, tests with acetylcholine will also be performed in order to evaluate the possible presence of epicardial (focal or diffuse) or microvascular spasm.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Clinical presentation of chronic ischemic heart disease (IHD), requiring coronaryangiography for the diagnosis
  • Absence of obstructive CAD at coronary angiography
  • Age > 18 years
  • Ability to provide a valid informed consent to the study procedure at the time ofbaseline evaluation

Exclusion

Exclusion Criteria:

  • Clinical presentation of acute coronary syndrome (ACS) or cardiogenic shock
  • Presence of obstructive CAD with at least 1 significant coronary artery stenosis,defined as diameter stenosis >50% and FFR ≤0.80 (or iFR/RFR ≤0.89)
  • Previous coronary artery bypass grafting (CABG)
  • Left ventricular systolic dysfunction, defined as ejection fraction (EF) <40%
  • Severe valvular heart disease
  • Pregnant or breastfeeding women
  • Known hypersensitivity or contraindication to any of the drugs used for coronaryphysiology testing (adenosine, nitrates, acetylcholine)
  • Inability or unwillingness to provide a valid informed consent to the study procedureat the time of baseline evaluation

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: not required
Phase:
Study Start date:
December 01, 2021
Estimated Completion Date:
February 29, 2024

Connect with a study center

  • San Raffaele Hospital

    Milan, 20132
    Italy

    Site Not Available

  • Azienda Ospedaliera Universitaria Federico II,

    Napoli, 80131
    Italy

    Site Not Available

  • Fondazione Policlinico Universitario A. Gemelli IRCCS,

    Roma, 00168
    Italy

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.